Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Prenatal Diagnosis|February 17, 2017
Elevation of glycosaminoglycans in the amniotic fluid of a fetus with mucopolysaccharidosis VIIFrancyne Kubaski, Ana Carolina Brusius-Facchin, Robert W Mason, et al.
Cancer|April 21, 2021
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohortSandip Pravin Patel, Edward Mayerson, Young Kwang Chae, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Safety and Clinical Activity of MEDI0562, a Humanized OX40 Agonist Monoclonal Antibody, in Adult Patients with Advanced Solid TumorsBonnie S Glisson, Rom S Leidner, Robert L Ferris, et al.
Nature Communications|May 20, 2026
microRNA-25 drives immune checkpoint therapy resistance by repressing innate and humoral immunity via Syndecan-3Zhouting Zhu, Wenyan Han, Yufei Deng, et al.
Nature|March 28, 2020
Microbiome analyses of blood and tissues suggest cancer diagnostic approachGregory D Poore, Evguenia Kopylova, Qiyun Zhu, et al.
Pediatric Endocrinology Reviews : PER|October 28, 2014
Morquio A syndrome: diagnosis and current and future therapiesShunji Tomatsu, Eriko Yasuda, Pravin Patel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2023
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief ReportDong-Wan Kim, Sang-We Kim, D Ross Camidge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2024
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar CancersYoung Kwang Chae, Lucy Corthell, Sandip Pravin Patel, et al.
Therapeutic Advances in Medical Oncology|November 25, 2024
Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2021
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid TumorsSylvie Rottey, Jeffrey Clarke, Kyaw Aung, et al.
Pageof 11